Eden Research plc (LON:EDEN – Get Free Report) insider Sean M. Smith bought 426,986 shares of the business’s stock in a transaction on Tuesday, April 1st. The shares were acquired at an average cost of GBX 234 ($3.03) per share, with a total value of £999,147.24 ($1,291,722.35).
Eden Research Stock Performance
LON EDEN opened at GBX 2.58 ($0.03) on Wednesday. The stock has a fifty day simple moving average of GBX 3.36 and a 200-day simple moving average of GBX 3.71. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a market cap of £13.78 million, a PE ratio of -9.05 and a beta of 0.92. Eden Research plc has a twelve month low of GBX 2.26 ($0.03) and a twelve month high of GBX 5.22 ($0.07).
Eden Research Company Profile
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- Using the MarketBeat Dividend Tax Calculator
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.